Primary hyperparathyroidism (pHPT) is increasingly diagnosed due to routine serum calcium screening, leading to evolving management approaches. Recently, there has been a notable rise in the occurrence of diseases as a result of the implementation of regular serum calcium screening. Previously, diagnosis often followed complications such as kidney